FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2157082409> ?p ?o ?g. }

• W2157082409 endingPage "83" @default.
• W2157082409 startingPage "76" @default.
• W2157082409 abstract "The purpose of this research was to determine the toxicity and immunological activity of large multivalent immunogen (LMI), a preparation of tumor cell membranes affixed to amorphous silica microbeads, in patients with melanoma.Nineteen patients with metastatic (stage IV) melanoma were entered into the study, of whom 15 received the full 3 months of treatment with LMI. LMI was administered without adjuvant, one-half intradermally (i.d.) and the other half s.c. Because we expected little toxicity, we first treated 2 patients at each dose level, 10-, 30-, or 100-million tumor cell equivalents on weeks 0, 4, and 8, and subsequently randomized the remaining 13 patients to receive treatment with one of those dosage schedules, for a total of 19 patients. Two patients who were registered were found to be ineligible because of brain metastases, and 2 others did not complete the course of treatment for reasons other than toxicity. Thus, 15 patients were fully evaluable. Patients with evidence of a clinical response (at least stable disease at the 12-week checkpoint) had the option of continuing treatment at 4-week intervals. Frequencies of cytolytic T cell precursors against HLA-A2 matched melanoma cells, and delayed-type hypersensitivity to a melanoma cell membrane preparation from a component melanoma cell line were performed to measure immunological efficacy, and serum chemistries and complete blood counts were performed every 2 weeks throughout the study to measure possible toxicity. Computed tomography scans were performed pretreatment and at week 12 to measure possible beneficial effects on known lesions.Eight of the 15 evaluable patients had an increase in cytolytic T-cell precursors during the course of therapy, usually by day 42. No patient had demonstrable delayed-type hypersensitivity to a melanoma membrane preparation before or after treatment. No toxicity of any kind was observed. A degree of clinical effectiveness of LMI was suggested by the elicitation of stable disease in 5 patients at 12 weeks. One patient had >50% regression of a lung nodule but progression of disease to the brain, whereas a second patient had a bona fide partial remission of a 3-cm diameter solitary lung nodule.LMI was nontoxic, improved immunological reactivity to melanoma cells, and showed evidence of clinical effectiveness (shrinkage of tumor) in 1 patient. Additional studies with LMI with added adjuvant materials, in melanoma and other cancers, appear warranted." @default.
• W2157082409 created "2016-06-24" @default.
• W2157082409 creator A5016707073 @default.
• W2157082409 creator A5039446676 @default.
• W2157082409 creator A5040498222 @default.
• W2157082409 creator A5052891844 @default.
• W2157082409 creator A5062133875 @default.
• W2157082409 creator A5063520696 @default.
• W2157082409 date "2004-01-01" @default.
• W2157082409 modified "2023-09-26" @default.
• W2157082409 title "Phase I Trial of Large Multivalent Immunogen Derived from Melanoma Lysates in Patients with Disseminated Melanoma" @default.
• W2157082409 cites W1480063679 @default.
• W2157082409 cites W1707974959 @default.
• W2157082409 cites W1831933605 @default.
• W2157082409 cites W1881016703 @default.
• W2157082409 cites W1972423862 @default.
• W2157082409 cites W1975809043 @default.
• W2157082409 cites W1991317669 @default.
• W2157082409 cites W1992847016 @default.
• W2157082409 cites W2006987944 @default.
• W2157082409 cites W2026599056 @default.
• W2157082409 cites W2034311985 @default.
• W2157082409 cites W2077329371 @default.
• W2157082409 cites W2081774451 @default.
• W2157082409 cites W2092010202 @default.
• W2157082409 cites W2115195875 @default.
• W2157082409 cites W2125163888 @default.
• W2157082409 cites W2129449089 @default.
• W2157082409 cites W2130506075 @default.
• W2157082409 cites W2140477051 @default.
• W2157082409 cites W2239850217 @default.
• W2157082409 cites W2243393118 @default.
• W2157082409 doi "https://doi.org/10.1158/1078-0432.ccr-0689-3" @default.
• W2157082409 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14734454" @default.
• W2157082409 hasPublicationYear "2004" @default.
• W2157082409 type Work @default.
• W2157082409 sameAs 2157082409 @default.
• W2157082409 citedByCount "30" @default.
• W2157082409 countsByYear W21570824092012 @default.
• W2157082409 countsByYear W21570824092013 @default.
• W2157082409 countsByYear W21570824092014 @default.
• W2157082409 countsByYear W21570824092015 @default.
• W2157082409 countsByYear W21570824092016 @default.
• W2157082409 countsByYear W21570824092019 @default.
• W2157082409 countsByYear W21570824092022 @default.
• W2157082409 countsByYear W21570824092023 @default.
• W2157082409 crossrefType "journal-article" @default.
• W2157082409 hasAuthorship W2157082409A5016707073 @default.
• W2157082409 hasAuthorship W2157082409A5039446676 @default.
• W2157082409 hasAuthorship W2157082409A5040498222 @default.
• W2157082409 hasAuthorship W2157082409A5052891844 @default.
• W2157082409 hasAuthorship W2157082409A5062133875 @default.
• W2157082409 hasAuthorship W2157082409A5063520696 @default.
• W2157082409 hasBestOaLocation W21570824091 @default.
• W2157082409 hasConcept C126322002 @default.
• W2157082409 hasConcept C141071460 @default.
• W2157082409 hasConcept C159654299 @default.
• W2157082409 hasConcept C203014093 @default.
• W2157082409 hasConcept C2777658100 @default.
• W2157082409 hasConcept C2777863537 @default.
• W2157082409 hasConcept C2779909307 @default.
• W2157082409 hasConcept C29730261 @default.
• W2157082409 hasConcept C502942594 @default.
• W2157082409 hasConcept C542903549 @default.
• W2157082409 hasConcept C71924100 @default.
• W2157082409 hasConcept C90924648 @default.
• W2157082409 hasConceptScore W2157082409C126322002 @default.
• W2157082409 hasConceptScore W2157082409C141071460 @default.
• W2157082409 hasConceptScore W2157082409C159654299 @default.
• W2157082409 hasConceptScore W2157082409C203014093 @default.
• W2157082409 hasConceptScore W2157082409C2777658100 @default.
• W2157082409 hasConceptScore W2157082409C2777863537 @default.
• W2157082409 hasConceptScore W2157082409C2779909307 @default.
• W2157082409 hasConceptScore W2157082409C29730261 @default.
• W2157082409 hasConceptScore W2157082409C502942594 @default.
• W2157082409 hasConceptScore W2157082409C542903549 @default.
• W2157082409 hasConceptScore W2157082409C71924100 @default.
• W2157082409 hasConceptScore W2157082409C90924648 @default.
• W2157082409 hasIssue "1" @default.
• W2157082409 hasLocation W21570824091 @default.
• W2157082409 hasLocation W21570824092 @default.
• W2157082409 hasOpenAccess W2157082409 @default.
• W2157082409 hasPrimaryLocation W21570824091 @default.
• W2157082409 hasRelatedWork W112891057 @default.
• W2157082409 hasRelatedWork W2003938723 @default.
• W2157082409 hasRelatedWork W2047967234 @default.
• W2157082409 hasRelatedWork W2118496982 @default.
• W2157082409 hasRelatedWork W2154397091 @default.
• W2157082409 hasRelatedWork W2218622802 @default.
• W2157082409 hasRelatedWork W2353786173 @default.
• W2157082409 hasRelatedWork W2439875401 @default.
• W2157082409 hasRelatedWork W4238867864 @default.
• W2157082409 hasRelatedWork W2525756941 @default.
• W2157082409 hasVolume "10" @default.
• W2157082409 isParatext "false" @default.
• W2157082409 isRetracted "false" @default.
• W2157082409 magId "2157082409" @default.
• W2157082409 workType "article" @default.